Company: ANTX
Filing Date: 2025-03-25
Form Type: 10-K
Source: 0000950170-25-044366
Chunk: 153

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-03-25
Form: 10-K
Item: Item 1B
Chunk 153
---
 Employee Stock Purchase Plan.
     
    10-K
     
    001-41331
     
    10.6
     
    March 29, 2024

    10.7#
     
    AN2 Therapeutics, Inc. 2022 Non-Employee Director Compensation Policy.
     
    S-1
     
    333-263295
     
    10.7
     
    March 4, 2022

    10.8#
     
    AN2 Therapeutics, Inc. Officer Severance Plan.
     
    S-1
     
    333-263295
     
    10.8
     
    March 4, 2022

    10.9#
     
    Form of Indemnity Agreement by and between the Registrant and its directors and executive officers.
     
    S-1
     
    333-263295
     
    10.9
     
    March 4, 2022

    10.10#
     
    Offer Letter by and between the Registrant and Eric Easom, dated November 19, 2019.
     
    S-1
     
    333-263295
     
    10.10
     
    March 4, 2022

    10.11#
     
    Offer Letter by and between the Registrant and Lucy Day, dated November 19, 2019.
     
    S-1
     
    333-263295
     
    10.11
     
    March 4, 2022

    10.12#
     
    Offer Letter by and between the Registrant and Sanjay Chanda, dated November 19, 2019.
     
    S-1
     
    333-263295
     
    10.12
     
    March 4, 2022

    10.13‡
     
    License Agreement by and between the Registrant and Anacor Pharmaceuticals, Inc., dated November 20, 2019, as amended on December 3, 2021.
     
    S-1
     
    333-263295
     
    10.13
     
    March 4, 2022

    10.14‡